In the 25 years since its first description the p53 protein has been shown to play a key role in both tumour suppression and aging. New discoveries about the function and control of p53 continue to emerge every month and attempts to exploit the system to develop better therapeutics and diagnostics are beginning to be successful in the clinic (1,2). © Oxford University Press 2004; all rights reserved.
CITATION STYLE
Lane, D. P. (2004). p53 from pathway to therapy. Carcinogenesis, 25(7), 1077–1081. https://doi.org/10.1093/carcin/bgh186
Mendeley helps you to discover research relevant for your work.